Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Storer

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
Environmental and Molecular Mutagenesis|September 5, 2002
Genotoxicity of naturally occurring indole compounds: correlation between covalent DNA binding and other genotoxicity testsM Vijayaraj Reddy, Richard D Storer, George M Laws, et al.
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
In search of effective therapies to overcome resistance to Temozolomide in brain tumoursKaouthar Bouzinab, Helen Summers, Jihong Zhang, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 16, 2009
Hemangiosarcoma in rodents: mode-of-action evaluation and human relevanceSamuel M Cohen, Richard D Storer, Kay A Criswell, et al.
Scientific Reports|August 12, 2018
Tissue metabolite profiles for the characterisation of paediatric cerebellar tumoursChristopher D Bennett, Sarah E Kohe, Simrandip K Gill, et al.
Neuro-Oncology|October 28, 2010
Pediatric brain tumor cancer stem cells: cell cycle dynamics, DNA repair, and etoposide extrusionDeema Hussein, Wiyada Punjaruk, Lisa C D Storer, et al.
Toxicologic Pathology|June 14, 2011
An analysis of pharmaceutical experience with decades of rat carcinogenicity testing: support for a proposal to modify current regulatory guidelinesFrank D Sistare, Daniel Morton, Carl Alden, et al.
Acta Neuropathologica|March 16, 2018
Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic targetJohn R Apps, Gabriela Carreno, Jose Mario Gonzalez-Meljem, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
Environmental and Molecular Mutagenesis|September 5, 2002
Genotoxicity of naturally occurring indole compounds: correlation between covalent DNA binding and other genotoxicity testsM Vijayaraj Reddy, Richard D Storer, George M Laws, et al.
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
In search of effective therapies to overcome resistance to Temozolomide in brain tumoursKaouthar Bouzinab, Helen Summers, Jihong Zhang, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 16, 2009
Hemangiosarcoma in rodents: mode-of-action evaluation and human relevanceSamuel M Cohen, Richard D Storer, Kay A Criswell, et al.
Scientific Reports|August 12, 2018
Tissue metabolite profiles for the characterisation of paediatric cerebellar tumoursChristopher D Bennett, Sarah E Kohe, Simrandip K Gill, et al.
Neuro-Oncology|October 28, 2010
Pediatric brain tumor cancer stem cells: cell cycle dynamics, DNA repair, and etoposide extrusionDeema Hussein, Wiyada Punjaruk, Lisa C D Storer, et al.
Toxicologic Pathology|June 14, 2011
An analysis of pharmaceutical experience with decades of rat carcinogenicity testing: support for a proposal to modify current regulatory guidelinesFrank D Sistare, Daniel Morton, Carl Alden, et al.
Acta Neuropathologica|March 16, 2018
Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic targetJohn R Apps, Gabriela Carreno, Jose Mario Gonzalez-Meljem, et al.
Pageof 9